An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.
Any purulent skin disease (Dorland, 27th ed).
A skin ulcer is a breakdown of the skin's surface and underlying tissues, often caused by prolonged pressure, infection, or poor circulation, leading to a loss of continuity in the epidermis and dermis, potentially extending into deeper layers such as subcutaneous tissue, muscle, and bone.
An ulcerative pyoderma usually caused by group A beta-hemolytic streptococcal infection at the site of minor trauma. (Dorland, 27th ed)
Pathological processes involving the PENIS or its component tissues.
Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.
An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.
A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.
Skin diseases caused by bacteria, fungi, parasites, or viruses.
Horizontal and, to a lesser degree, axial movement of a tooth in response to normal forces, as in occlusion. It refers also to the movability of a tooth resulting from loss of all or a portion of its attachment and supportive apparatus, as seen in periodontitis, occlusal trauma, and periodontosis. (From Jablonski, Dictionary of Dentistry, 1992, p507 & Boucher's Clinical Dental Terminology, 4th ed, p313)
A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.
The removal of foreign material and devitalized or contaminated tissue from or adjacent to a traumatic or infected lesion until surrounding healthy tissue is exposed. (Dorland, 27th ed)
Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles ERYTHEMA MULTIFORME. Sweet syndrome is associated with LEUKEMIA.
A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)
A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.
Substances that reduce or suppress INFLAMMATION.
Drugs used to treat or prevent skin disorders or for the routine care of skin.
A number of small lung lesions characterized by small round masses of 2- to 3-mm in diameter. They are usually detected by chest CT scans (COMPUTED TOMOGRAPHY, X-RAY). Such nodules can be associated with metastases of malignancies inside or outside the lung, benign granulomas, or other lesions.
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
A cutaneous pouch of skin containing the testicles and spermatic cords.
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
Incorrect diagnoses after clinical examination or technical diagnostic procedures.

Pyoderma gangrenosum with lung injury. (1/93)

A 24 year old woman with airway injury, lung infiltration and pleural effusion due to pyoderma gangrenosum is reported.  (+info)

Pyoderma gangrenosum. A diagnosis not to be missed. (2/93)

We describe a case of pyoderma gangrenosum which presented with severe wound breakdown after elective hip replacement. The patient was treated successfully with minimal wound debridement and steroids. This diagnosis should always be considered when confronted with an enlarging painful skin lesion which does not grow organisms when cultured and fails to respond to antibiotic therapy, especially if there are similar lesions in other sites. In patients who have a past history of pyoderma gangrenosum, prophylactic steroids may be indicated at the time of surgery or may be required early in the postoperative period.  (+info)

Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. (3/93)

Pyoderma gangrenosum, cystic acne, and aseptic arthritis are clinically distinct disorders within the broad class of inflammatory diseases. Although this triad of symptoms is rarely observed in a single patient, a three-generation kindred with autosomal-dominant transmission of these three disorders has been reported as "PAPA syndrome" (MIM 604416). We report mapping of a disease locus for familial pyoderma gangrenosum-acne-arthritis to the long arm of chromosome 15 (maximum two-point LOD score, 5.83; recombination fraction [straight theta] 0 at locus D15S206). Under the assumption of complete penetrance, haplotype analysis of recombination events defined a disease interval of 10 cM, between D15S1023 and D15S979. Successful identification of a single disease locus for this syndrome suggests that these clinically distinct disorders may share a genetic etiology. These data further indicate the role of genes outside the major histocompatibility locus in inflammatory disease.  (+info)

Cutaneous blastomycosis in New Brunswick: case report. (4/93)

Blastomycosis is a fungal infection of immunocompetent hosts. We present a case of cutaneous blastomycosis acquired in New Brunswick, which provides evidence that this disease is endemic in Atlantic Canada. This case also demonstrates that the diagnosis of blastomycosis may be elusive. Perseverance, a high index of clinical suspicion and close cooperation with the microbiology laboratory may be required to diagnose this uncommon condition.  (+info)

Understanding pyoderma gangrenosum: a review. (5/93)

CONTEXT: Diagnosis and management of pyoderma gangrenosum, a chronic, ulcerative cutaneous inflammatory disease often associated with systemic disease, requires a multidisciplinary approach. No large-scale, controlled trials have been conducted and, as a consequence, the knowledge of this condition is largely based on anecdotal reports. OBJECTIVE: To investigate current understanding of the diagnosis and management of pyoderma gangrenosum. DESIGN: Critical review article. Two hundred eighty-six articles, limited to articles in English and pertaining to humans, were retrieved and reviewed from a MEDLINE search spanning the years 1960-2000. CONCLUSIONS: Diagnosis of pyoderma gangrenosum often requires consultation by multiple specialists in different fields of medicine. Treatment is individually tailored and depends on disease severity and the presence of associated disease. Local treatment is sufficient for mild disease, and the use of immunosuppressive agents is reserved for severe or refractory cases, with cyclosporin being the agent of choice. The long-term outcome for these patients has not been established.  (+info)

Clinical use of Infliximab in Crohn's disease: the Edinburgh experience. (6/93)

Infliximab is an established treatment for steroid-resistant and fistulating Crohn's disease. Although efficacy has been shown in clinical trials, financial implications often limit its use and limited data exist regarding clinical practice. AIMS: To audit the clinical effectiveness of Infliximab. METHODS: We prospectively audited 50 consecutive patients [28 females; median age, 34 years (17-70 years)]. Disease activity and response rates were assessed by the Harvey-Bradshaw index. Clinical and disease data were collected and blood was taken for inflammatory markers, complement and double-stranded DNA antibodies. Patients received Infliximab at 5 mg/kg and were followed for 12 weeks. RESULTS: Indications for Infliximab were refractory Crohn's disease in 39 patients, fistulating Crohn's disease in six, pyoderma gangrenosum in one, pouchitis in two and coeliac disease in two. Thirty-one (79%) of the refractory Crohn's disease patients and four (66%) of the fistulating patients responded at 4 weeks. Twenty-one (54%) of the refractory Crohn's disease patients had a continued response at 12 weeks. Perianal disease was more prevalent in non-responders (7/8 vs. 12/31, P < 0.02). CONCLUSIONS: Response rates to Infliximab in our group are comparable to those of clinical trials. Despite the expense, it remains a useful adjunct to treatment in this otherwise difficult group of patients. Patients with perianal disease responded less well in our cohort.  (+info)

Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. (7/93)

PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne, OMIM #604416) and familial recurrent arthritis (FRA) are rare inherited disorders of early onset, primarily affecting skin and joint tissues. Recurring inflammatory episodes lead to accumulation of sterile, pyogenic, neutrophil-rich material within the affected joints, ultimately resulting in significant destruction. We recently localized the genes for PAPA syndrome and FRA to chromosome 15q and suggested that they are the same disorder. We have now established this by the identification of co-segregating disease-causing mutations in the CD2-binding protein 1 (CD2BP1; GenBank accession no XM 044569) gene in the two reported families with this disorder. E250Q or A230T amino acid substitutions occur within a domain highly homologous to yeast cleavage furrow-associated protein CDC15. CD2BP1 and its murine ortholog, proline-serine-threonine phosphatase interacting protein (PSTPIP1), are adaptor proteins known to interact with PEST-type protein tyrosine phosphatases (PTP). Yeast two-hybrid assays demonstrate severely reduced binding between PTP PEST and both the E250Q and A230T mutant proteins. Previous evidence supports the integral role of CD2BP1 and its interacting proteins in actin reorganization during cytoskeletal-mediated events. We hypothesize that the disease-causing mutations that we have identified compromise physiologic signaling necessary for the maintenance of proper inflammatory response. Accordingly we suggest classification of PAPA syndrome as an autoinflammatory disease. This CD2BP1-mediated biochemical pathway(s) may function in common inflammatory disorders with apparent etiological overlap, such as rheumatoid arthritis and inflammatory bowel disease.  (+info)

Skin ulcers misdiagnosed as pyoderma gangrenosum. (8/93)

BACKGROUND: Pyoderma gangrenosum is a diagnosis of exclusion, and the misdiagnosis of pyoderma gangrenosum can result in substantial complications in patients who have other causes of severe cutaneous ulceration. METHODS: We reviewed the charts of 240 patients with a diagnosis of pyoderma gangrenosum who were evaluated at our institution from 1975 through 2000, including 157 consecutive patients treated for presumed pyoderma gangrenosum from 1984 through 1992. We also reviewed the English-language literature. RESULTS: Ninety-five patients (49 from our institution and 46 described in the literature) had skin ulcers with a clinical resemblance to pyoderma gangrenosum. The final diagnoses were vascular occlusive or venous disease, vasculitis, cancer, primary infection, drug-induced or exogenous tissue injury, and other inflammatory disorders. Of the 95 patients studied, 64 had been treated for pyoderma gangrenosum for a median of 10 months (range, 3 to 180). These 64 included 15 of the 157 consecutive patients treated for pyoderma gangrenosum at our institution (10 percent). Of the ulcers in the 64 patients treated for pyoderma gangrenosum, it was clear that those in 23 patients (36 percent) did not respond to treatment directed at pyoderma gangrenosum, those in 8 (12 percent) were exacerbated by such treatment, and those in 15 (23 percent) improved with such treatment. CONCLUSIONS: The misdiagnosis of pyoderma gangrenosum is not uncommon and exposes patients to risks associated with its treatment. A thorough evaluation is required in all patients suspected of having pyoderma gangrenosum in order to rule out alternative diagnoses.  (+info)

Pyoderma gangrenosum is a rare, inflammatory skin condition that typically begins as a small pustule or blister, which then rapidly progresses to form painful ulcers with a characteristic violaceous (bluish-purple) undermined border. The etiology of pyoderma gangrenosum is not entirely clear, but it's often associated with an underlying systemic disease, such as inflammatory bowel disease, rheumatoid arthritis, or hematologic disorders.

The pathophysiology of pyoderma gangrenosum involves a dysregulated immune response and neutrophil-mediated tissue damage. Diagnosis is often based on the clinical presentation and exclusion of other conditions with similar lesions. Treatment typically includes systemic immunosuppressive therapy, such as corticosteroids, cyclosporine, or biologic agents, along with local wound care to promote healing and prevent infection.

It's important to note that pyoderma gangrenosum can be a challenging condition to manage, and a multidisciplinary approach involving dermatologists, internists, and surgeons may be necessary for optimal care.

Pyoderma is a term used in medicine to describe a bacterial skin infection. It's derived from two Greek words: "pyon" meaning pus and "derma" meaning skin.

The infection can result in inflammation, often characterized by redness, swelling, warmth, and pain. Pus-filled blisters or boils may also form, which can rupture and crust over as the infection progresses.

Pyoderma can occur in people of all ages but is particularly common in children. The causative bacteria are often Staphylococcus aureus or Streptococcus pyogenes. The condition can be superficial, affecting only the top layer of the skin (epidermis), or it can be deeper, involving the dermis and/or subcutaneous tissue.

Treatment typically involves antibiotics, either topical or oral, depending on the severity and extent of the infection. In some cases, drainage of pus-filled abscesses may be necessary. Preventive measures such as good hygiene and keeping skin clean and dry can help reduce the risk of pyoderma.

A skin ulcer is a defined as a loss of continuity or disruption of the skin surface, often accompanied by inflammation and/or infection. These lesions can result from various causes including pressure, venous or arterial insufficiency, diabetes, and chronic dermatological conditions. Skin ulcers are typically characterized by their appearance, depth, location, and underlying cause. Common types of skin ulcers include pressure ulcers (also known as bedsores), venous leg ulcers, arterial ulcers, and diabetic foot ulcers. Proper evaluation, wound care, management of underlying conditions, and prevention strategies are crucial in the treatment of skin ulcers to promote healing and prevent complications.

Ecthyma is a deep skin infection that penetrates below the superficial skin layer (dermis) and is characterized by the formation of ulcers or crusty lesions. It is typically caused by group A Streptococcus or Staphylococcus aureus bacteria and can occur in individuals with compromised immune systems, poor hygiene, or exposure to unhygienic conditions.

The infection usually begins as a papule or pustule, which then develops into a shallow ulcer with a necrotic base and raised edges. The lesion may be painful, pruritic (itchy), and can take several weeks to heal, often leaving scars. In severe cases, ecthyma can lead to complications such as lymphangitis, cellulitis, or bacteremia.

Treatment typically involves the use of systemic antibiotics, topical antiseptics, and wound care to promote healing and prevent scarring. Preventive measures include maintaining good hygiene, prompt treatment of skin injuries, and addressing underlying conditions that may increase the risk of infection.

Penile diseases refer to a range of medical conditions that affect the penis, including infections, inflammatory conditions, and structural abnormalities. Some common penile diseases include:

1. Balanitis: an infection or inflammation of the foreskin and/or head of the penis.
2. Balanoposthitis: an infection or inflammation of both the foreskin and the head of the penis.
3. Phimosis: a condition in which the foreskin is too tight to be pulled back over the head of the penis.
4. Paraphimosis: a medical emergency in which the foreskin becomes trapped behind the head of the penis and cannot be returned to its normal position.
5. Peyronie's disease: a condition characterized by the development of scar tissue inside the penis, leading to curvature during erections.
6. Erectile dysfunction: the inability to achieve or maintain an erection sufficient for sexual intercourse.
7. Penile cancer: a rare form of cancer that affects the skin and tissues of the penis.

These conditions can have various causes, including bacterial or fungal infections, sexually transmitted infections (STIs), skin conditions, trauma, or underlying medical conditions. Treatment for penile diseases varies depending on the specific condition and its severity, but may include medications, surgery, or lifestyle changes.

A leg ulcer is a chronic wound that occurs on the lower extremities, typically on the inner or outer ankle. It's often caused by poor circulation, venous insufficiency, or diabetes. Leg ulcers can also result from injury, infection, or inflammatory diseases such as rheumatoid arthritis or lupus. These ulcers can be painful, and they may take a long time to heal, making them prone to infection. Proper diagnosis, treatment, and wound care are essential for healing leg ulcers and preventing complications.

Erythema nodosum is a type of inflammation that occurs in the fatty layer of the skin, causing painful, red or purple bumps (nodules) to form. It is a type of panniculitis, which refers to any condition that causes inflammation of the fatty layer of tissue beneath the skin.

Erythema nodosum is often associated with a variety of underlying conditions, such as infections (e.g., streptococcus, tuberculosis), medications (e.g., sulfa drugs, oral contraceptives), inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis), and pregnancy.

The bumps associated with erythema nodosum typically appear on the shins, ankles, knees, or other areas of the legs, although they can also occur on the arms, hands, or face. The bumps may be tender to the touch, warm, and swollen, and they may cause pain or discomfort when walking or standing for prolonged periods.

In most cases, erythema nodosum resolves on its own within a few weeks to several months, although symptoms can be managed with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Treating the underlying condition is also important for resolving erythema nodosum and preventing recurrences.

Acne vulgaris is a common skin condition characterized by the formation of various types of blemishes on the skin, such as blackheads, whiteheads, papules, pustules, and cysts or nodules. These lesions typically appear on areas of the body that have a high concentration of sebaceous glands, including the face, neck, chest, back, and shoulders.

Acne vulgaris occurs when hair follicles become clogged with dead skin cells and excess oil (sebum) produced by the sebaceous glands. This blockage provides an ideal environment for bacteria, particularly Propionibacterium acnes, to multiply, leading to inflammation and infection. The severity of acne vulgaris can range from mild with only a few scattered comedones (blackheads or whiteheads) to severe cystic acne, which can cause significant scarring and emotional distress.

The exact causes of acne vulgaris are not fully understood, but several factors contribute to its development, including:

1. Hormonal changes during puberty, menstruation, pregnancy, or due to conditions like polycystic ovary syndrome (PCOS)
2. Genetic predisposition
3. Use of certain medications, such as corticosteroids and lithium
4. Excessive production of sebum due to overactive sebaceous glands
5. Accumulation of dead skin cells that clog pores
6. Bacterial infection (particularly Propionibacterium acnes)
7. Inflammation caused by the body's immune response to bacterial infection and clogged pores

Treatment for acne vulgaris depends on its severity and can include over-the-counter or prescription topical treatments, oral medications, chemical peels, light therapies, or even hormonal therapies in some cases. It is essential to seek professional medical advice from a dermatologist or healthcare provider to determine the most appropriate treatment plan for individual needs.

Infectious skin diseases are conditions characterized by an infection or infestation of the skin caused by various microorganisms such as bacteria, viruses, fungi, or parasites. These organisms invade the skin, causing inflammation, redness, itching, pain, and other symptoms. Examples of infectious skin diseases include:

1. Bacterial infections: Cellulitis, impetigo, folliculitis, and MRSA (methicillin-resistant Staphylococcus aureus) infections are examples of bacterial skin infections.
2. Viral infections: Herpes simplex virus (HSV), varicella-zoster virus (VZV), human papillomavirus (HPV), and molluscum contagiosum are common viruses that can cause skin infections.
3. Fungal infections: Tinea pedis (athlete's foot), tinea corporis (ringworm), candidiasis (yeast infection), and pityriasis versicolor are examples of fungal skin infections.
4. Parasitic infestations: Scabies, lice, and bed bugs are examples of parasites that can cause infectious skin diseases.

Treatment for infectious skin diseases depends on the underlying cause and may include topical or oral antibiotics, antiviral medications, antifungal treatments, or insecticides to eliminate parasitic infestations. Proper hygiene, wound care, and avoiding contact with infected individuals can help prevent the spread of infectious skin diseases.

Tooth mobility, also known as loose teeth, refers to the degree of movement or displacement of a tooth in its socket when lateral forces are applied. It is often described in terms of grades:

* Grade 1: Tooth can be moved slightly (up to 1 mm) with finger pressure.
* Grade 2: Tooth can be moved up to 2 mm with finger pressure.
* Grade 3: Tooth can be moved more than 2 mm or can be removed from its socket with manual pressure.

Increased tooth mobility can be a sign of periodontal disease, trauma, or other dental conditions and should be evaluated by a dentist. Treatment may include deep cleaning, splinting, or surgery to restore stability to the affected teeth.

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that typically affects areas of the body where there are sweat glands, such as the armpits, groin, and buttocks. The main features of HS are recurrent boil-like lumps or abscesses (nodules) that form under the skin. These nodules can rupture and drain pus, leading to painful, swollen, and inflamed lesions. Over time, these lesions may heal, only to be replaced by new ones, resulting in scarring and tunnel-like tracts (sinus tracts) beneath the skin.

HS is a debilitating condition that can significantly impact an individual's quality of life, causing physical discomfort, emotional distress, and social isolation. The exact cause of HS remains unclear, but it is thought to involve a combination of genetic, hormonal, and environmental factors. Treatment options for HS include topical and oral antibiotics, biologic therapies, surgical interventions, and lifestyle modifications, such as weight loss and smoking cessation.

Debridement is a medical procedure that involves the removal of dead, damaged, or infected tissue to improve the healing process or prevent further infection. This can be done through various methods such as surgical debridement (removal of tissue using scalpel or scissors), mechanical debridement (use of wound irrigation or high-pressure water jet), autolytic debridement (using the body's own enzymes to break down and reabsorb dead tissue), and enzymatic debridement (application of topical enzymes to dissolve necrotic tissue). The goal of debridement is to promote healthy tissue growth, reduce the risk of infection, and improve overall wound healing.

Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a skin condition characterized by the rapid onset of painful, red, and swollen skin lesions. The lesions are often accompanied by fever and elevated white blood cell count, particularly an increase in neutrophils.

The medical definition of Sweet syndrome includes the following criteria:

1. Abrupt onset of painful, erythematous (red), and edematous (swollen) papules, plaques, or nodules.
2. Fever greater than 38°C (100.4°F).
3. Leukocytosis with a predominance of neutrophils in the peripheral blood.
4. Histopathological evidence of a dense dermal infiltrate of neutrophils without evidence of vasculitis.
5. Rapid response to systemic corticosteroids.

Sweet syndrome can be associated with various medical conditions, such as infections, malignancies, and inflammatory diseases, or it can occur without an identifiable underlying cause (idiopathic).

Dapsone is a medication that belongs to a class of drugs called sulfones. It is primarily used to treat bacterial skin infections such as leprosy and dermatitis herpetiformis (a skin condition associated with coeliac disease). Dapsone works by killing the bacteria responsible for these infections.

In addition, dapsone has anti-inflammatory properties and is sometimes used off-label to manage inflammatory conditions such as vasculitis, bullous pemphigoid, and chronic urticaria. It is available in oral tablet form and topical cream or gel form.

Like all medications, dapsone can cause side effects, which may include nausea, loss of appetite, and headache. More serious side effects, such as methemoglobinemia (a blood disorder that affects the body's ability to transport oxygen), peripheral neuropathy (nerve damage that causes pain, numbness, or weakness in the hands and feet), and liver damage, can occur but are less common.

It is important for patients taking dapsone to be monitored by a healthcare provider to ensure safe and effective use of the medication.

A rare disease, also known as an orphan disease, is a health condition that affects fewer than 200,000 people in the United States or fewer than 1 in 2,000 people in Europe. There are over 7,000 rare diseases identified, and many of them are severe, chronic, and often life-threatening. The causes of rare diseases can be genetic, infectious, environmental, or degenerative. Due to their rarity, research on rare diseases is often underfunded, and treatments may not be available or well-studied. Additionally, the diagnosis of rare diseases can be challenging due to a lack of awareness and understanding among healthcare professionals.

Anti-inflammatory agents are a class of drugs or substances that reduce inflammation in the body. They work by inhibiting the production of inflammatory mediators, such as prostaglandins and leukotrienes, which are released during an immune response and contribute to symptoms like pain, swelling, redness, and warmth.

There are two main types of anti-inflammatory agents: steroidal and nonsteroidal. Steroidal anti-inflammatory drugs (SAIDs) include corticosteroids, which mimic the effects of hormones produced by the adrenal gland. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a larger group that includes both prescription and over-the-counter medications, such as aspirin, ibuprofen, naproxen, and celecoxib.

While both types of anti-inflammatory agents can be effective in reducing inflammation and relieving symptoms, they differ in their mechanisms of action, side effects, and potential risks. Long-term use of NSAIDs, for example, can increase the risk of gastrointestinal bleeding, kidney damage, and cardiovascular events. Corticosteroids can have significant side effects as well, particularly with long-term use, including weight gain, mood changes, and increased susceptibility to infections.

It's important to use anti-inflammatory agents only as directed by a healthcare provider, and to be aware of potential risks and interactions with other medications or health conditions.

Dermatologic agents are medications, chemicals, or other substances that are applied to the skin (dermis) for therapeutic or cosmetic purposes. They can be used to treat various skin conditions such as acne, eczema, psoriasis, fungal infections, and wounds. Dermatologic agents include topical corticosteroids, antibiotics, antifungals, retinoids, benzoyl peroxide, salicylic acid, and many others. They can come in various forms such as creams, ointments, gels, lotions, solutions, and patches. It is important to follow the instructions for use carefully to ensure safety and effectiveness.

Medical Definition: Multiple pulmonary nodules refer to multiple small rounded or irregularly shaped masses in the lungs, usually measuring less than 3 cm in diameter. These nodules can be caused by various conditions such as benign tumors, infections, inflammation, or malignancies like lung cancer. The presence of multiple pulmonary nodules often requires further evaluation with imaging studies and sometimes biopsy to determine the underlying cause and appropriate treatment.

Prednisolone is a synthetic glucocorticoid drug, which is a class of steroid hormones. It is commonly used in the treatment of various inflammatory and autoimmune conditions due to its potent anti-inflammatory and immunosuppressive effects. Prednisolone works by binding to specific receptors in cells, leading to changes in gene expression that reduce the production of substances involved in inflammation, such as cytokines and prostaglandins.

Prednisolone is available in various forms, including tablets, syrups, and injectable solutions. It can be used to treat a wide range of medical conditions, including asthma, rheumatoid arthritis, inflammatory bowel disease, allergies, skin conditions, and certain types of cancer.

Like other steroid medications, prednisolone can have significant side effects if used in high doses or for long periods of time. These may include weight gain, mood changes, increased risk of infections, osteoporosis, diabetes, and adrenal suppression. As a result, the use of prednisolone should be closely monitored by a healthcare professional to ensure that its benefits outweigh its risks.

Paraproteinemias refer to the presence of abnormal levels of paraproteins in the blood. Paraproteins are immunoglobulins (antibodies) produced by plasma cells, which are a type of white blood cell found in the bone marrow. In healthy individuals, paraproteins play a role in the immune system's response to infection and disease. However, in certain conditions, such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), and Waldenstrom macroglobulinemia, plasma cells produce excessive amounts of a single type of paraprotein, leading to its accumulation in the blood.

Paraproteinemias can cause various symptoms depending on the level of paraproteins present and their impact on organs and tissues. These symptoms may include fatigue, weakness, numbness or tingling in the extremities, bone pain, recurrent infections, and kidney problems. In some cases, paraproteinemias may not cause any symptoms and may only be detected during routine blood tests.

It is important to note that while paraproteinemias are often associated with plasma cell disorders, they can also occur in other conditions such as chronic inflammation or autoimmune diseases. Therefore, further testing and evaluation are necessary to determine the underlying cause of paraproteinemia and develop an appropriate treatment plan.

The scrotum is a part of the external male genitalia. It's a sac-like structure made up of several layers of skin and smooth muscle, which hangs down behind and beneath the penis. The primary function of the scrotum is to maintain the testicles at a temperature slightly lower than the core body temperature, which is optimal for sperm production.

The scrotum contains two compartments, each one housing a testicle. It's located in the pubic region and is usually visible externally. The skin of the scrotum is thin and wrinkled, which allows it to expand and contract depending on the temperature, accommodating the shrinking or swelling of the testicles.

Please note that while I strive to provide accurate information, this definition is intended to be a general overview and should not replace professional medical advice.

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the lining of the large intestine (colon) and rectum. In ulcerative colitis, the lining of the colon becomes inflamed and develops ulcers or open sores that produce pus and mucous. The symptoms of ulcerative colitis include diarrhea, abdominal pain, and rectal bleeding.

The exact cause of ulcerative colitis is not known, but it is thought to be related to an abnormal immune response in which the body's immune system attacks the cells in the digestive tract. The inflammation can be triggered by environmental factors such as diet, stress, and infections.

Ulcerative colitis is a chronic condition that can cause symptoms ranging from mild to severe. It can also lead to complications such as anemia, malnutrition, and colon cancer. There is no cure for ulcerative colitis, but treatment options such as medications, lifestyle changes, and surgery can help manage the symptoms and prevent complications.

Diagnostic errors refer to inaccurate or delayed diagnoses of a patient's medical condition, which can lead to improper or unnecessary treatment and potentially serious harm to the patient. These errors can occur due to various factors such as lack of clinical knowledge, failure to consider all possible diagnoses, inadequate communication between healthcare providers and patients, and problems with testing or interpretation of test results. Diagnostic errors are a significant cause of preventable harm in medical care and have been identified as a priority area for quality improvement efforts.

... of all cases of pyoderma Bullous pyoderma gangrenosum Pustular pyoderma gangrenosum Vegetative pyoderma gangrenosum The ... Pyoderma gangrenosum is a rare, inflammatory skin disease where painful pustules or nodules become ulcers that progressively ... Also in support of an immune cause is the finding that at least half of all pyoderma gangrenosum patients suffer from immune- ... Pyoderma gangrenosum ulcers demonstrate pathergy, that is, a worsening in response to minor trauma or surgical debridement. ...
However a new pyoderma gangrenosum ulcer has started on my lo... ... However a new pyoderma gangrenosum ulcer has started on my ... Please feel welcome to drop into the Anxiety and Panic Forum as our fearless leader-moderator has Pyoderma Gangrenosum. I ...
Pyoderma gangrenosum is an uncommon, ulcerative cutaneous condition of uncertain etiology. It is associated with systemic ... Pyoderma gangrenosum occurs in about 1 in 100,000 persons each year in the United States. Although pyoderma gangrenosum affects ... encoded search term (Pyoderma Gangrenosum) and Pyoderma Gangrenosum What to Read Next on Medscape ... Death from pyoderma gangrenosum is rare, but it may occur due to an associated disease or as a result of therapy. ...
Pyoderma gangrenosum is an uncommon, ulcerative cutaneous condition of uncertain etiology. It is associated with systemic ... Pyoderma gangrenosum may occur on the genitalia. This form, termed vulvar or penile pyoderma gangrenosum, must be ... encoded search term (Pyoderma Gangrenosum) and Pyoderma Gangrenosum What to Read Next on Medscape ... Classic pyoderma gangrenosum may occur around stoma sites; this type, shown in the image below, is known as peristomal pyoderma ...
Pyoderma gangrenosum treatment includes gradual removal of dead tissue. Many patients who suffer from this condition may also ... Pyoderma gangrenosum refers to a form of skin ulceration that may affect any person of any age or gender. Pyoderma gangrenosum ... Pyoderma gangrenosum ulcers may heal themselves or may continue to expand. In some cases, pyoderma gangrenosum may reach a ... While these conditions do increase the risk of pyoderma gangrenosum, they are not listed as causes of pyoderma gangrenosum. ...
Pyoderma gangrenosum (PG) lacks consensus regarding treatment, and no prior studies assess treatment satisfaction in PG. The ... Treatment of pyoderma gangrenosum: A multicenter survey-based study assessing satisfaction and quality of life Dermatol Ther. ... Pyoderma gangrenosum (PG) lacks consensus regarding treatment, and no prior studies assess treatment satisfaction in PG. The ...
... in Child. See also in: Cellulitis DDx,Anogenital. Captions Print Filter Images View all Images (14). (with ... Pyoderma gangrenosum in Child. See also in: Cellulitis DDx,Anogenital. Print Images (14) ... Pyoderma gangrenosum (PG) is an inflammatory, noninfectious, ulcerative neutrophilic skin disease of uncertain etiology ... L88 - Pyoderma gangrenosum. SNOMEDCT:. 74578003 - Pyoderma gangrenosum. Look For. Copy. Subscription Required ...
Pyoderma gangrenosum (PG) presents as a rapidly enlarging, very painful ulcer and is diagnosed by its characteristic appearance ... Ulcerative and pustular types of pyoderma gangrenosum may arise.. What causes pyoderma gangrenosum?. Pyoderma gangrenosum is an ... Clinical features of pyoderma gangrenosum, Cribriform scar, Superficial pyoderma gangrenosum, Bullous pyoderma gangrenosum, ... What is pyoderma gangrenosum?. Pyoderma gangrenosum (PG) presents as a rapidly enlarging, very painful ulcer. It is one of a ...
Pyoderma gangrenosum. *ICD-9-CM 686.01 is a billable medical code that can be used to indicate a diagnosis on a reimbursement ...
Return to Article Details Rapid Improvement of Pyoderma Gangrenosum Managed with IV Methylprednisolone Download Download PDF ...
Renal impairment has been reported in association with pyoderma gangrenosum but has notbeen described in PASH syndrome. We ... pyoderma gangrenosum, acne, and suppurative hidradenitis) forms part of the spectrum of autoinflammatory diseases. We report an ... Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with ... PASH syndrome (pyoderma gangrenosum, acne, and suppurative hidradenitis) forms part of the spectrum of autoinflammatory ...
The causes and management atypical wounds including pyoderma gangrenosum, calciphylaxis, and sickle cell ulcers are discussed ... Pyoderma Gangrenosum. pyoderma gangrenosum is an uncommon, non-infectious autoimmune disorder that is associated with ... Treatment of pyoderma gangrenosum involves topical wound care with use of topical steroids, protective dressings, and even ...
Imatinib-induced pyoderma gangrenosum in a patient with… May 31, 2021 *Primary cutaneous CD8+ aggressive epidermotropic T-cell… ... Bullous pyoderma gangrenosum associated with ulcerative colitis. Chandra Lal Naik1 , Gurcharan Singh1 , Lekshman Kumar2 , K ... Pyoderma gangrenosum commonly occurs in immunosuppressed patients secondary to accompanying disease, infections or therapy. [1] ... Pyoderma gangrenosum (PG) is a rare non-infectious neutrophilic dermatosis associated with underlying systemic disease, ...
Consecutive Cases of Pyoderma Gangrenosum Following Dermatologic Surgery August 1, 2020 J Clin Aesthet Dermatol. 2020;13(8):49- ... A Second Case of Sunitinib-associated Pyoderma Gangrenosum August 5, 2010 Steven M. Dean, DO, FACP, RPVI; Matthew Zirwas, MD ... Pyoderma Gangrenosum-associated Granulomatosis with Polyangitis: A Case Report and Literature Review October 1, 2017 ... Pyoderma Gangrenosum in a Patient with Brutons X-linked Agammaglobulinemia: Shared Pathogenesis of Altered Tumor Necrosis ...
Pyoderma Gangrenosum - Learn about the causes, symptoms, diagnosis & treatment from the MSD Manuals - Medical Consumer Version. ... What is pyoderma gangrenosum? Pyoderma gangrenosum is a skin disease in which you get large sores on your skin, usually on your ... What causes pyoderma gangrenosum? Doctors dont know exactly what causes pyoderma gangrenosum, but they think it involves a ... How can doctors tell if I have pyoderma gangrenosum? Doctors can usually tell if you have pyoderma gangrenosum by looking at ...
Diagnosis of pyoderma gangrenosum can be problematic as no specific diagnostic features can be identified from biopsies and no ... it is important to have a thorough understanding of the patients medical history so that risk factors for pyoderma gangrenosum ... Diagnosis of pyoderma gangrenosum can be problematic as no specific diagnostic features can be identified from biopsies and no ... Diagnosis of Pyoderma Gangrenosum & Risk Factors. Wound Care Education » Diagnosis of Pyoderma Gangrenosum & Risk Factors ...
Lesions of pyoderma gangrenosum mimicking sweets syndrome; A diagnostic dilemma. Maqbool Saep, SpandanaP Hegde, Prema Saldanha ... Management strategies for pyoderma gangrenosum: Case studies and Review of literature. Ann Plast Surg 2001;47:310-5. [PUBMED] [ ... Management of pyoderma gangrenosum - An update. Indian J Dermatol Venereol Leprol 2004;70:329-35. [PUBMED] ... Pyoderma gangrenosum (PG) is an inflammatory condition of the skin, which was first described by Brunsting et al, in 1930. The ...
The Association between Erythema Nodosum (EN) and Pyoderma Gangrenosum (PG) in Pediatric Inflammatory Bowel Disease (IBD). ...
Carlo Crosti works at Dipartimento di Fisiopatologia Medico-Chirurgica e and is well known for Pyoderma Gangrenosum, Basal Cell ... pyoderma gangrenosum , pyoderma gangrenosum pg , pyoderma gangrenosum acne , pyoderma gangrenosum patients , pyoderma ... Key People For Pyoderma Gangrenosum. Top KOLs in the world #1 Harold * *****. pyoderma gangrenosum herpes zoster pemphigus ... Also Ranks for: Inflammatory Bowel Diseases , pyoderma gangrenosum , sweet syndrome , neutrophilic dermatoses , treatment pg. ...
Dive into the research topics of Pyoderma gangrenosum near a cystostomy catheter. Together they form a unique fingerprint. ...
... is a chronic skin ulceration occurring usually on the legs but can appear anywhere on the body. ...
Pyoderma gangrenosum is an uncommon, ulcerative cutaneous condition of uncertain etiology. It is associated with systemic ... Pyoderma gangrenosum occurs in about 1 in 100,000 persons each year in the United States. Although pyoderma gangrenosum affects ... encoded search term (Pyoderma Gangrenosum) and Pyoderma Gangrenosum What to Read Next on Medscape ... Death from pyoderma gangrenosum is rare, but it may occur due to an associated disease or as a result of therapy. ...
Pyoderma gangrenosum. This skin symptom can be the result of ulcerative colitis or Crohns disease. It forms painful ulcers on ... Pyoderma gangrenosum can be diagnosed with a skin biopsy. Treatment can be quite challenging for the patient and require a ... This is the clinical, rare form of pyoderma gangrenosum. Lesions of pustules form in the folds of the patients skin and ...
Pyoderma Gangrenosum. Partridge and colleagues (2018) noted that pyoderma gangrenosum (PG) is a neutrophilic dermatosis with ... Anakinra appears less efficacious in patients with pyoderma gangrenosum. The authors concluded that IL-1 antagonists are a ... Abdallah HB, Fogh K, Vestergaard C, Bech R. Pyoderma gangrenosum and interleukin inhibitors: A semi-systematic review. ... Effectiveness of systemic treatments for pyoderma gangrenosum: A systematic review of observational studies and clinical trials ...
Pyoderma Gangrenosum. Pyoderma Gangrenosum. July 22, 2020. by Data Trace Editor - Discusison:. - not to be confused w/ pyogenic ... squamous cell carcinoma: Squamous-Cell Carcinoma Resembling Pyoderma Gangrenosum - Clinical Findings:. - appearance of ... Pyoderma grangrenosum of the hand: a case series and review of the literature. ...
Pyoderma gangrenosum is a rare cause of chronic, recurrent and painful non-infectious skin ulcers. It is classified as a ... Pyoderma gangrenosum. What is pyoderma gangrenosum?. Pyoderma gangrenosum is a rare cause of chronic, recurrent and painful non ... How is pyoderma gangrenosum diagnosed?. It is difficult to diagnose pyoderma gangrenosum as there is no specific test for the ... What is the likely outcome of pyoderma gangrenosum?. Pyoderma gangrenosum is a treatable condition but it may take months to ...
Pyoderma Gangrenosum - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical ... Etiology of Pyoderma Gangrenosum Etiology of pyoderma gangrenosum is unknown, but it can be associated with various systemic ... Pathophysiology of Pyoderma Gangrenosum Pathophysiology of pyoderma gangrenosum is poorly understood but may involve problems ... Symptoms and Signs of Pyoderma Gangrenosum Most often, pyoderma gangrenosum begins as an inflamed erythematous papule, pustule ...
Pyoderma gangrenosum (PG) is an uncommon & noninfectious neutrophilic dermatosis commonly associated with underlying systemic ... PYODERMA GANGRENOSUM SECONDARY TO TAKAYASUS ARTERITIS. Document. Metadata. Title. PYODERMA GANGRENOSUM SECONDARY TO TAKAYASUS ... Pyoderma gangrenosum (PG) is an uncommon & noninfectious neutrophilic dermatosis commonly associated with underlying systemic ...
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the ... Wilson-Jones E., Winkelmann R.K. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am ... Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma). Int J Dermatol 2013; 52 (6): 753-756. ... Fox L.P., Geyer A.S., Husain S., Grossman M.E. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous ...
  • The exact cause of pyoderma gangrenosum is unknown. (ahdubai.com)
  • The exact cause of pyoderma gangrenosum associated with RA is not fully understood. (patientcareonline.com)
  • Pyoderma gangrenosum is a rare, inflammatory skin disease where painful pustules or nodules become ulcers that progressively grow. (wikipedia.org)
  • Pyoderma gangrenosum ulcers demonstrate pathergy, that is, a worsening in response to minor trauma or surgical debridement. (wikipedia.org)
  • Essential type II mixed cryoglobulinemia causing pyoderma gangrenosum-like ulcers. (medscape.com)
  • Pyoderma gangrenosum (pie-o-DUR-muh gang-ruh-NO-sum) is a rare condition that causes large, painful sores (ulcers) to develop on your skin, most often on your legs. (ahdubai.com)
  • Pyoderma gangrenosum ulcers can develop quickly. (ahdubai.com)
  • If you have pyoderma gangrenosum, new skin trauma, such as a cut or puncture wound, may trigger new ulcers. (ahdubai.com)
  • The necrotizing ulcers of pyoderma gangrenosum can mimic severe bacterial infection as well as Sweet syndrome, collagen-vascular diseases, halogenodermas, malignant neoplasms, factitial ulcerations, brown recluse spider bites, bullous erythema multiforme, and purpura fulminans. (patientcareonline.com)
  • We report a case of pyoderma gangrenosum with a local infection in a 58-year-old man's leg that showed improvement in symptoms within a relatively short period, through surgical treatment using negative pressure wound therapy and a dermal substitute. (jwmr.org)
  • 4. A case of pyoderma gangrenosum possibly associated with sunitinib treatment. (nih.gov)
  • Ayyala RS, Armstrong S. Corneal melting and scleromalacia perforans in a patient with pyoderma gangrenosum and acute myeloid leukemia. (medscape.com)
  • This report describes a patient with pyoderma gangrenosum (PG), in whom there were co-existent lung abnormalities. (journalmc.org)
  • 8. Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid. (nih.gov)
  • Patients who have bullous (atypical) pyoderma gangrenosum should be monitored with periodic clinical assessment and complete blood count for development of a hematologic disorder. (msdmanuals.com)
  • Apart from the ulcerative variant, the other subtypes of pyoderma gangrenosum observed are bullous, vegetative, pustular, peristomal, and superficial granulomatous pyoderma gangrenosum. (jsstd.org)
  • Superficial granulomatous pyoderma Brown recluse spider bite Jackson JM, Callen JP (April 23, 2012). (wikipedia.org)
  • 12. Pyoderma gangrenosum in a patient with chronic granulomatous disease: A case report. (nih.gov)
  • Pyoderma gangrenosum (PG) is a chronic inflammatory cutaneous disease of unknown etiology. (journalmc.org)
  • 2. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib? (nih.gov)
  • People with a digestive tract disease such as ulcerative colitis or Crohn's disease are at increased risk of pyoderma gangrenosum. (ahdubai.com)
  • Dhanesh D, Jayapalan S, Nair PS, Sudhesan A. Pyoderma gangrenosum with Marfan syndrome and Crohn's disease: A rare association. (jsstd.org)
  • Although inflammatory bowel disease is a well-known association of pyoderma gangrenosum, we did not come across any previous reports of coexistence of pyoderma gangrenosum, Crohn's disease, and Marfan syndrome. (jsstd.org)
  • The endpoint was closure of enterocutaneous fistulas and complete healing of Pyoderma Gangrenosum and perineal Crohn's disease. (scielo.br)
  • citation needed] One hallmark of pyoderma gangrenosum is pathergy, which is the appearance of new lesions at sites of trauma, including surgical wounds. (wikipedia.org)
  • The breakdown at the harvest site is a clue to the diagnosis and is an indicator of pathergy often seen in active pyoderma gangrenosum patients. (medscape.com)
  • The pathergy phenomenon was responsible for the start of pyoderma gangrenosum in 16.3% (95% CI 7.7-27.1) of patients. (physiciansweekly.com)
  • 2,6 Pathergy occurs in 20% to 30% of patients with pyoderma gangrenosum. (patientcareonline.com)
  • Factitial ulceration on the scalp from chronic manipulation mimicking an ulceration of pyoderma gangrenosum. (medscape.com)
  • Diagnosis of pyoderma gangrenosum is clinical and is a diagnosis of exclusion after other causes of ulceration have been ruled out. (msdmanuals.com)
  • Expansion of ulceration after surgical debridement strongly suggests pyoderma gangrenosum. (msdmanuals.com)
  • A detailed evaluation ruled out other causes for skin ulceration and we made a diagnosis of pyoderma gangrenosum. (jsstd.org)
  • 9. Pyoderma gangrenosum-like ulceration of the lower extremity secondary to sunitinib therapy: a case report. (nih.gov)
  • Pyogenic arthritis-pyoderma gangrenosum-acne syndrome is a rare pleiotropic autoinflammatory disorder of childhood, primarily affecting the joints and skin. (sjelden.no)
  • Ten patients with pyoderma gangrenosum, seven female and three male, 25 to 94 years old, mainly with multiple lesions, have been treated with clofazimine, 100 mg three times daily. (nih.gov)
  • The most common symptom of canine pyoderma gangrenosum is the presence of ulcerative lesions on the skin. (9iner.com)
  • In addition to the skin lesions, dogs with pyoderma gangrenosum may also experience fever, lethargy, and loss of appetite. (9iner.com)
  • One such condition is canine pyoderma gangrenosum, a rare skin disease that can cause ulcerative lesions on your dog's skin. (9iner.com)
  • The symptoms of canine pyoderma gangrenosum can vary from dog to dog, but the most common sign is the appearance of ulcerative lesions on the skin. (9iner.com)
  • Ahmad K, Ramsay B. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma. (medscape.com)
  • González-Moreno J, Ruíz-Ruigomez M, Callejas Rubio J, Ríos Fernández R, Ortego Centeno N. Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature. (medscape.com)
  • Systemic polyarteritis nodosa mimicking pyoderma gangrenosum in a rare association with small lymphocytic leukaemia/chronic lymphocytic leukaemia. (medscape.com)
  • The frequency and distribution of underlying systemic illnesses among individuals with pyoderma gangrenosum are not well understood. (physiciansweekly.com)
  • For a review, researchers compiled current information on the incidence of concomitant systemic disorders in pyoderma gangrenosum patients. (physiciansweekly.com)
  • Pyoderma gangrenosum is a chronic, neutrophilic, progressive skin necrosis of unknown etiology often associated with systemic illness and sometimes skin injury. (msdmanuals.com)
  • 1-3,5-7 More than 50% of patients with pyoderma gangrenosum have an underlying systemic disease and up to 37% have associated arthritis. (patientcareonline.com)
  • For instance, ulcerative colitis, rheumatoid arthritis, and multiple myeloma (MM) have all been associated with pyoderma gangrenosum. (wikipedia.org)
  • 13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. (nih.gov)
  • Pyoderma gangrenosum and ulcerative colitis. (bmj.com)
  • People who have certain underlying conditions, such as inflammatory bowel disease or arthritis, are at higher risk of pyoderma gangrenosum. (ahdubai.com)
  • In some cases, canine pyoderma gangrenosum may be triggered by an underlying medical condition, such as inflammatory bowel disease or cancer. (9iner.com)
  • Pyoderma gangrenosum (PG) is rare, but often associated with different forms of arthritis, in particular rheumatoid arthritis and inflammatory bowel diseases. (rheumnow.com)
  • Pyoderma gangrenosum is a non-infectious, inflammatory, and neutrophilic dermatosis. (jsstd.org)
  • Background Pyoderma gangrenosum is a rare inflammatory skin condition. (elsevierpure.com)
  • 3 Certain identifiable factors (including skin fragility, arterial disease, peripheral edema, nutritional status, and venous insufficiency) can predis-pose patients with RA to pyoderma gangrenosum. (patientcareonline.com)
  • 1. Sunitinib induced pyoderma gangrenosum-like ulcerations. (nih.gov)
  • Superficial Variant of Pyoderma Gangrenosum Successfully Treated with Lower Dose Clofazimine. (nih.gov)
  • Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. (medscape.com)
  • Diagnosing pyoderma gangrenosum. (patientcareonline.com)
  • Diagnosing canine pyoderma gangrenosum can be challenging because it is a rare condition and the symptoms can be similar to other skin diseases. (9iner.com)
  • Pyoderma gangrenosum is a diagnosis of exclusion. (jsstd.org)
  • The Genetics of Pyoderma Gangrenosum and Implications for Treatment: A Systematic Review. (medscape.com)
  • A new agent for the treatment of pyoderma gangrenosum. (nih.gov)
  • Treatment of pyoderma gangrenosum is aimed at reducing inflammation, controlling pain, promoting wound healing and controlling any underlying disease. (ahdubai.com)
  • Because pyoderma gangrenosum can be made worse by cuts to the skin, surgery to remove dead tissue is not usually considered a good treatment option. (ahdubai.com)
  • In this article, we will explore the causes, symptoms, and treatment options for Canine Pyoderma Gangrenosum. (9iner.com)
  • Treatment of canine pyoderma gangrenosum typically involves a combination of medications and supportive care. (9iner.com)
  • With prompt diagnosis and treatment, many dogs with pyoderma gangrenosum can recover and live a happy, healthy life. (9iner.com)
  • Some studies have shown benefits of hyperbaric oxygen therapy (HBOT) especially in the treatment of complex perineal wounds, pyoderma gangrenosum (PG) and fistulizing disease 4 4. (scielo.br)
  • Tacrolimus has also shown efficacy in the treatment of psoriasis , rosacea, and pyoderma gangrenosum. (buzzrx.com)
  • 4. Understand the causes and treatments for neutrophilic disorders, including pyoderma gangrenosum. (utmb.edu)
  • 20. [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. (nih.gov)
  • The exact causes of pyoderma gangrenosum are unknown, but it appears to be a disorder of the immune system. (ahdubai.com)
  • People with acute myelogenous leukemia, myelodysplasia or a myeloproliferative disorder are at increased risk of pyoderma gangrenosum. (ahdubai.com)
  • The exact cause of canine pyoderma gangrenosum is unknown, but it is believed to be an autoimmune disorder. (9iner.com)
  • Happle R, Schiffer HP, Kövary PM. Ocular involvement in pyoderma gangrenosum. (medscape.com)
  • Vadillo M, Jucgla A, Podzamczer D, Rufi G, Domingo A. Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia. (medscape.com)
  • 18. Pyoderma gangrenosum with pulmonary involvement? (nih.gov)
  • Pyoderma gangrenosum (PG), acne(A), and Suppurative hidradenitis (SH) syndrome (PASHs) is a recently proposed disease entity clinically characterized by PG, acne, and SH, belonging to the spectrum of hereditary autoinflammatory syndrome with PG. (adacyte.com)
  • 10. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases. (nih.gov)
  • The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum. (medscape.com)
  • Pyoderma gangrenosum treated with clofazimine: clinical evaluation of 7 cases. (nih.gov)
  • This is the clinical, rare form of pyoderma gangrenosum. (news-medical.net)
  • I see some studies showing this is a potential met, but others showing it could be pyoderma gangrenosum or a version of some other autoimmune disease. (cancer.org)
  • 19. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia. (nih.gov)
  • Rietjens M, Cuccia G, Brenelli F, Manconi A, Martella S, De Lorenzi F. A Pyoderma Gangrenosum Following Breast Reconstruction: A Rare Cause of Skin Necrosis. (medscape.com)
  • Pyoderma gangrenosum usually starts with a small, red bump on your skin, which may resemble a spider bite. (ahdubai.com)
  • Suspect pyoderma gangrenosum in a patient with RA who presents with an ulcerative skin lesion. (patientcareonline.com)
  • IL-8 is not expressed in normal skin but is overexpressed in certain chronic skin conditions, such as pyoderma gangrenosum. (patientcareonline.com)
  • Pyoderma gangrenosum can be diagnosed with a skin biopsy. (news-medical.net)
  • Canine Pyoderma Gangrenosum is a rare skin disease that affects dogs. (9iner.com)
  • Dogs are prone to various skin diseases, and one of the rarest and most severe is canine pyoderma gangrenosum. (9iner.com)
  • Canine pyoderma gangrenosum is a rare and severe skin disease that can be challenging to diagnose and treat. (9iner.com)
  • Pyoderma gangrenosum is a rare ulcerative skin lesion that occurs primarily on the lower extremities for which surgical debridement and skin grafting have been traditionally contraindicated. (jwmr.org)
  • 6. Sunitinib-induced pyoderma gangrenosum-like skin ulcer. (nih.gov)
  • Pyoderma gangrenosum and other bowel and arthritis associated neutrophilic dermatoses. (medscape.com)
  • Poor prognosis of arthritis-associated pyoderma gangrenosum. (patientcareonline.com)
  • Two prospective studies have evaluated treatments for pyoderma gangrenosum using a primary outcome of healing speed at 6 weeks. (elsevierpure.com)
  • The pyoderma gangrenosum (PG) is a neutrophilic disease, rare but with a poor outcome. (rbcp.org.br)
  • In support of an immune cause, a variety of immune mediators such as interleukin (IL)-8, IL-1β, IL-6, interferon (IFN)-γ, granulocyte colony-stimulating factor, tumor necrosis factor alpha, matrix metalloproteinase (MMP)-9, MMP10, and elafin have all been reported to be elevated in patients with pyoderma gangrenosum. (wikipedia.org)
  • Also in support of an immune cause is the finding that at least half of all pyoderma gangrenosum patients suffer from immune-mediated diseases. (wikipedia.org)
  • Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. (medscape.com)
  • The quantitative synthesis included 21 eligible studies with a total of 2,611 pyoderma gangrenosum patients. (physiciansweekly.com)
  • 7 In a study of 86 patients who had pyoderma gangrenosum, 14% had RA. (patientcareonline.com)
  • Pathophysiology of pyoderma gangrenosum is poorly understood but may involve problems with neutrophil chemotaxis. (msdmanuals.com)
  • Conclusion Speed of healing, IGA, and resolution of inflammation were all shown to be good predictors of eventual healing of pyoderma gangrenosum. (elsevierpure.com)